These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7813068)

  • 1. Role of low-density lipoproteins in atherogenesis and development of coronary heart disease.
    Grundy SM
    Clin Chem; 1995 Jan; 41(1):139-46. PubMed ID: 7813068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
    Parthasarathy S; Steinberg D; Witztum JL
    Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small LDL and its clinical importance as a new CAD risk factor: a female case study.
    Superko HR; Nejedly M; Garrett B
    Prog Cardiovasc Nurs; 2002; 17(4):167-73. PubMed ID: 12417832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].
    Sniderman A; Shapiro S; Marpole D; Skinner B; Teng B; Kwiterovich PO
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):604-8. PubMed ID: 6928647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL subfractions and atherogenicity: an hypothesis from the University of Glasgow.
    Packard CJ
    Curr Med Res Opin; 1996; 13(7):379-90. PubMed ID: 8862937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.
    Swinkels DW; Demacker PN; Hendriks JC; Brenninkmeijer BJ; Stuyt PM
    Atherosclerosis; 1989 May; 77(1):59-67. PubMed ID: 2719763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Small, dense LDL].
    Yoshino G; Hirano T; Kazumi T
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():554-62. PubMed ID: 11351649
    [No Abstract]   [Full Text] [Related]  

  • 9. [New approach from lipoprotein disorders to atherosclerosis].
    Shirai K; Watanabe H; Murano T; Miyashita Y; Tozuka M
    Rinsho Byori; 1998 Jul; 46(7):689-94. PubMed ID: 9721537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism and clinical significance of lipoprotein Lp(a) (author's transl)].
    Krempler F
    Acta Med Austriaca; 1980; 7(4-5):101-3. PubMed ID: 6454320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolism and possible mechanisms of atherogenesis induced by lipoprotein (a)].
    Krempler F
    Wien Klin Wochenschr Suppl; 1984; 151():1-12. PubMed ID: 6091345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the structure of atherogenic lipoproteins in experimental atherosclerosis].
    Formaziuk VE; Dobretsov GE; Polesskiĭ VA; Torkhovskaia TI; Gerasimova EN
    Vopr Med Khim; 1980; 26(4):540-5. PubMed ID: 7456398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein predictors of the severity of coronary artery disease in men and women.
    Reardon MF; Nestel PJ; Craig IH; Harper RW
    Circulation; 1985 May; 71(5):881-8. PubMed ID: 3986978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the sialic acid content of low-density lipoprotein (LDL) and autoantibodies to oxidized LDL in the plasma of healthy subjects and patients with atherosclerosis.
    Cerne D; Jürgens G; Ledinski G; Kager G; Greilberger J; Lukac-Bajalo J
    Clin Chem Lab Med; 2002 Jan; 40(1):15-20. PubMed ID: 11916265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid abnormalities and coronary heart disease.
    Grundy SM
    Clin Symp; 1997; 49(4):1-32. PubMed ID: 9444788
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lipid peroxidation--the factor promoting cholesterol accumulation in cells in atherogenesis].
    Panasenko OM; Vol'nova TV; Azizova OA; Vladimirov IuA
    Biull Eksp Biol Med; 1988 Sep; 106(9):277-80. PubMed ID: 3167175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis.
    Barakat HA; Carpenter JW; McLendon VD; Khazanie P; Leggett N; Heath J; Marks R
    Diabetes; 1990 Dec; 39(12):1527-33. PubMed ID: 2245877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic basis of primary hypercholesterolemia.
    Vega GL; Denke MA; Grundy SM
    Circulation; 1991 Jul; 84(1):118-28. PubMed ID: 2060088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized lipoproteins in blood plasma: possible marker of atherosclerosis progression.
    Moriel P; Okawabata FS; Abdalla DS
    IUBMB Life; 1999 Oct; 48(4):413-7. PubMed ID: 10632571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.